Market Overview

Kedalion Therapeutics to Present at Biotech Showcase 2019

Share:

Kedalion Therapeutics, Inc., a clinical-stage company focused on the
development and commercialization of topical ophthalmology therapies
based on its proprietary AcuStream™ platform, today announced that Peter
Noymer, PhD, the Company's President and CEO, will be presenting at the
Biotech Showcase 2019 at the Hilton San Francisco Union Square in San
Francisco, CA. Details of the presentation are below:

Date: Monday, January 7, 2019

 

Time: 10:30 a.m. PDT

 

Location: Franciscan B (Ballroom
Level)

 

About Kedalion Therapeutics

Kedalion Therapeutics is a venture-backed, clinical-stage biotechnology
company whose mission is to bring to market transformative topical
ophthalmic therapies for new and existing indications. Kedalion's
proprietary AcuStream platform technology delivers topical drugs to the
eye in a precise and accurate manner that enables comparable effect with
up to an 80% reduction in dose compared to standard eye drops. Kedalion
is based in Menlo Park, CA. For more information, visit www.kedalionthera.com.

View Comments and Join the Discussion!
 
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com